Morphine and alternative opioids in cancer pain: the EAPC recommendations
Top Cited Papers
Open Access
- 5 March 2001
- journal article
- guideline
- Published by Springer Nature in British Journal of Cancer
- Vol. 84 (5) , 587-593
- https://doi.org/10.1054/bjoc.2001.1680
Abstract
An expert working group of the European Association for Palliative Care has revised and updated its guidelines on the use of morphine in the management of cancer pain. The revised recommendations presented here give guidance on the use of morphine and the alternative strong opioid analgesics which have been introduced in many parts of the world in recent years. Practical strategies for dealing with difficult situations are described presenting a consensus view where supporting evidence is lacking. The strength of the evidence on which each recommendation is based is indicated. © 2001 Cancer Research CampaignKeywords
This publication has 30 references indexed in Scilit:
- Driving ability in cancer patients receiving long-term morphine analgesiaThe Lancet, 1995
- Opioid rotation for toxicity reduction in terminal cancer patientsJournal of Pain and Symptom Management, 1995
- Transdermal fentanyl: Clinical pharmacologyJournal of Pain and Symptom Management, 1992
- Opioid-responsive and opioid-non-responsive pain in cancerBritish Medical Bulletin, 1991
- Rectal, Buccal, and Sublingual Narcotics for the Management of Cancer PainJournal of Palliative Care, 1991
- Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer painThe Lancet, 1991
- Clinical Pharmacokinetics of MorphineTherapeutic Drug Monitoring, 1991
- Breakthrough pain: definition, prevalence and characteristicsPAIN®, 1990
- Morphine and oxycodone hydrochloride in the management of cancer painClinical Pharmacology & Therapeutics, 1990
- The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers.British Journal of Clinical Pharmacology, 1989